Green Park & Golf Ventures — 2019 Investments
3 investments dated 2019 · listed companies and verified rows first · show all
Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases.
BiotechHealthtechMedical DevicesAustin, US
Matt Pauls(Chair of the Board of Directors and Chief Executive Officer)inMike Ciesla(Executive Officer)Badrul Chowdhury(Executive Officer)inSantosh J. Vetticaden(Executive Officer)Gregory D. Gorgas(Executive Officer)Patrick Keran(Executive Officer)
Co-investorsBain Capital Life SciencesCentral Texas Angel NetworkKeiretsu ForumMoore Venture PartnersNew Enterprise Associates (NEA)
Developer of next-generation insulin solutions
BiotechWaban, US
Richard Berenson(Executive Officer, Director, Promoter)David C. Sweeney(Director)
BoardTim Xiao(Director)inJohn Brooks(Mr. Brooks is the Chairman of the Board of Directors.)
Co-investorsDelos CapitalRobin Hood VenturesJumpstart VenturesSanofi Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.










